These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 16963677

  • 1. Improved clinical outcomes with utilization of a community-acquired pneumonia guideline.
    Dean NC, Bateman KA, Donnelly SM, Silver MP, Snow GL, Hale D.
    Chest; 2006 Sep; 130(3):794-9. PubMed ID: 16963677
    [Abstract] [Full Text] [Related]

  • 2. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
    Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.
    Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
    [Abstract] [Full Text] [Related]

  • 3. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia.
    Dean NC, Silver MP, Bateman KA, James B, Hadlock CJ, Hale D.
    Am J Med; 2001 Apr 15; 110(6):451-7. PubMed ID: 11331056
    [Abstract] [Full Text] [Related]

  • 4. Effectiveness of antimicrobial guidelines for community-acquired pneumonia in children.
    Smith MJ, Kong M, Cambon A, Woods CR.
    Pediatrics; 2012 May 15; 129(5):e1326-33. PubMed ID: 22492769
    [Abstract] [Full Text] [Related]

  • 5. Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community-acquired pneumonia.
    Houck PM, Bratzler DW, Nsa W, Ma A, Bartlett JG.
    Arch Intern Med; 2004 Mar 22; 164(6):637-44. PubMed ID: 15037492
    [Abstract] [Full Text] [Related]

  • 6. Guideline adherence and macrolides reduced mortality in outpatients with pneumonia.
    Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR.
    Respir Med; 2012 Mar 22; 106(3):451-8. PubMed ID: 22182341
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
    Reyes Calzada S, Martínez Tomas R, Cremades Romero MJ, Martínez Moragón E, Soler Cataluña JJ, Menéndez Villanueva R.
    Respir Med; 2007 Sep 22; 101(9):1909-15. PubMed ID: 17628462
    [Abstract] [Full Text] [Related]

  • 9. [Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia].
    Díaz A, Kuzmanic G, Platzer L, Sanfuentes F, Espinoza MA, Saldías F.
    Rev Med Chil; 2003 Aug 22; 131(8):847-56. PubMed ID: 14558238
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The impact of empiric antimicrobial therapy with a β-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia.
    Mortensen EM, Restrepo MI, Anzueto A, Pugh J.
    Crit Care; 2005 Dec 06; 10(1):R8. PubMed ID: 16420641
    [Abstract] [Full Text] [Related]

  • 12. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study.
    Capelastegui A, España PP, Quintana JM, Gorordo I, Ortega M, Idoiaga I, Bilbao A.
    Clin Infect Dis; 2004 Oct 01; 39(7):955-63. PubMed ID: 15472846
    [Abstract] [Full Text] [Related]

  • 13. Association Between Alcohol Use Disorders and Outcomes of Patients Hospitalized With Community-Acquired Pneumonia.
    Gupta NM, Lindenauer PK, Yu PC, Imrey PB, Haessler S, Deshpande A, Higgins TL, Rothberg MB.
    JAMA Netw Open; 2019 Jun 05; 2(6):e195172. PubMed ID: 31173120
    [Abstract] [Full Text] [Related]

  • 14. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
    Grenier C, Pépin J, Nault V, Howson J, Fournier X, Poirier MS, Cabana J, Craig C, Beaudoin M, Valiquette L.
    J Antimicrob Chemother; 2011 Jul 05; 66(7):1617-24. PubMed ID: 21586592
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival.
    Bodí M, Rodríguez A, Solé-Violán J, Gilavert MC, Garnacho J, Blanquer J, Jimenez J, de la Torre MV, Sirvent JM, Almirall J, Doblas A, Badía JR, García F, Mendia A, Jordá R, Bobillo F, Vallés J, Broch MJ, Carrasco N, Herranz MA, Rello J, Community-Acquired Pneumonia Intensive Care Units (CAPUCI) Study Investigators.
    Clin Infect Dis; 2005 Dec 15; 41(12):1709-16. PubMed ID: 16288392
    [Abstract] [Full Text] [Related]

  • 17. Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.
    Frei CR, Restrepo MI, Mortensen EM, Burgess DS.
    Am J Med; 2006 Oct 15; 119(10):865-71. PubMed ID: 17000218
    [Abstract] [Full Text] [Related]

  • 18. Effects of guideline-concordant antimicrobial therapy on mortality among patients with community-acquired pneumonia.
    Mortensen EM, Restrepo M, Anzueto A, Pugh J.
    Am J Med; 2004 Nov 15; 117(10):726-31. PubMed ID: 15541321
    [Abstract] [Full Text] [Related]

  • 19. Guideline-concordant therapy and reduced mortality and length of stay in adults with community-acquired pneumonia: playing by the rules.
    McCabe C, Kirchner C, Zhang H, Daley J, Fisman DN.
    Arch Intern Med; 2009 Sep 14; 169(16):1525-31. PubMed ID: 19752411
    [Abstract] [Full Text] [Related]

  • 20. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
    Nathan RV, Rhew DC, Murray C, Bratzler DW, Houck PM, Weingarten SR.
    Am J Med; 2006 Jun 14; 119(6):512.e1-7. PubMed ID: 16750965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.